A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- Alebund Pty Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT06100627
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Placebo 50 μgDrug: AP303 50 μgDrug: AP303 150 μgDrug: Placebo 150 μgDrug: AP303 300 μgDrug: Placebo 300 μgDrug: Placebo 600 μgDrug: AP303 600 μg
- First Posted Date
- 2022-08-17
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Alebund Pty Ltd
- Target Recruit Count
- 62
- Registration Number
- NCT05503693
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath